LncRNAs	Disease	Experimental methods	Regulated											Pubmed ID	Year
PART1	glioma	RT-qPCR, Western blot	L	✘	✘	✘	✘	✘	✘	✔	✘	✔	✘	32099409	2020
PART1	hepatocellular carcinoma	RNA-seq	H	✘	✘	✔	✘	✔	✔	✘	✘	✔	✘	30916406	2019
PART1	tongue squamous cell carcinoma	RNA-seq	L	✘	✘	✔	✘	✔	✔	✘	✘	✔	✘	30755833	2019
PART1	colorectal cancer	luciferase assay, RIP, RT-PCR	H	✘	✘	✘	✘	✔	✘	✔	✔	✔	✘	31898365	2020
PART1	colorectal cancer	qRT-PCR, Western Blot.Luciferase Reporter Assay, RIP	H	✘	✘	✘	✘	✔	✘	✔	✘	✔	✘	31669140	2020
PART1	esophageal squamous cell carcinoma	qPCR, Western blot, RIP	H	✔	✔	✘	✘	✘	✘	✘	✘	✔	✘	30049286	2018
PART1	Bladder Cancer	Microarray, qPCR	H	✘	✘	✘	✘	✘	✘	✔	✘	✔	✘	31311442	2019
PART1	colorectal cancer	qPCR, Western blot, luciferase reporter assay	H	✘	✘	✔	✘	✘	✘	✔	✘	✘	✘	28619512	2017
PART1	non small cell lung cancer	qPCR etc.	H	✘	✘	✔	✘	✔	✘	✘	✘	✘	✘	28819376	2017
PART1	prostate cancer	qCR, Western blotting, microarray etc.	H	✔	✘	✘	✘	✘	✔	✘	✘	✘	✘	29261512	2018
PART1	Myocardial ischemia-reperfusion injury	qRT-PCR;Dual-luciferase reporter assay;MTT assay	L	✘	✘	✘	✘	✘	✘	✘	✘	✔	✘	34082009	2021
PART1	Lung cancer	qRT-PCR	L	✘	✘	✔	✘	✘	✘	✘	✘	✘	✘	33346098	2021